J Gynecol Oncol.  2023 May;34(3):e56. 10.3802/jgo.2023.34.e56.

Trend and characteristics of minimally invasive surgery for patients with endometrial cancer in Japan

Affiliations
  • 1Department of Obstetrics and Gynecology, Tokai University School of Medicine, Kanagawa, Japan
  • 2Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Southern California, Los Angeles, CA, USA
  • 3Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, CA, USA
  • 4Department of Obstetrics and Gynecology, Kobe University School of Medicine, Hyogo, Japan
  • 5Department of Obstetrics and Gynecology, Fujita Health University School of Medicine, Aichi, Japan
  • 6Department of Obstetrics and Gynecology, Kyoto University School of Medicine, Kyoto, Japan
  • 7Department of Obstetrics and Gynecology, Nihon University School of Medicine, Tokyo, Japan
  • 8Department of Obstetrics and Gynecology, Kagoshima University School of Medicine, Kagoshima, Japan
  • 9Department of Obstetrics and Gynecology, Yamagata University School of Medicine, Yamagata, Japan

Abstract


Objective
Owing to the potential benefits of minimally invasive hysterectomy for endometrial cancer, the practice pattern has recently shifted in Japan. This study examined the trends in minimally invasive surgery (MIS) in patients with endometrial cancer in Japan.
Methods
This retrospective observational study examined the Japan Society of Obstetrics and Gynecology Tumor Registry database between 2015–2019. This study examined the time-specific proportion change and predictors of MIS use in initial endometrial cancer treatment in Japan, and compared it with the use of abdominal surgery. Additionally, the association between hospital surgical treatment volume and MIS use was examined.
Results
A total of 14,059 patients (26.5%) underwent minimally invasive hysterectomy, and 39,070 patients (73.5%) underwent abdominal hysterectomy in the study period. Patients who underwent MIS were more likely to be treated at high-volume centers, younger, central, or western Japan residents, registered in recent years, and had a tumor with stage I disease, type 1 histology, and less myometrial invasion (all adjusted p<0.05). The proportion of MIS treatments increased from 19.1% in 2015 to 34.3% in 2019 (p<0.001). On multivariable analysis, treatment at high-volume centers was a contributing factor for MIS (adjusted odds ratio=3.85; 95% confidence interval=3.44–4.30). MIS at high-volume centers increased significantly from 24.8% to 41.0% (p<0.001) during the study period, whereas MIS at low-volume centers remained at median 8.8%.
Conclusion
MIS has increased significantly in recent years, accounting for nearly 34% of surgical management of endometrial cancer in Japan. High-volume treatment centers take the lead in performing MIS.

Keyword

Endometrial Cancer; Minimally Invasive Surgery; Tendency; Hospitals; High-Volume
Full Text Links
  • JGO
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr